Renal Cell Carcinoma News and Research

Latest Renal Cell Carcinoma News and Research

Scientists to discuss the latest cancer therapies, advances in PSMA PET scans and many more at ASCO

Scientists to discuss the latest cancer therapies, advances in PSMA PET scans and many more at ASCO

Spatial organization of immune cells predicts outcomes for patients with clear cell renal cell carcinoma

Spatial organization of immune cells predicts outcomes for patients with clear cell renal cell carcinoma

Houston-based cancer survivor donates $10 million to accelerate translational research and clinical trials

Houston-based cancer survivor donates $10 million to accelerate translational research and clinical trials

New review examines link between HDLC and different types of cancer

New review examines link between HDLC and different types of cancer

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Recent therapeutic strategies for renal cell carcinoma and the effects of the tumor microenvironment on systemic therapy

Recent therapeutic strategies for renal cell carcinoma and the effects of the tumor microenvironment on systemic therapy

Two Cents' Worth: Shared decision making in renal cell carcinoma (RCC)

Two Cents' Worth: Shared decision making in renal cell carcinoma (RCC)

Cryoablation is more effective than heat-based treatment for some small kidney cancers

Cryoablation is more effective than heat-based treatment for some small kidney cancers

Triplet therapy slows progression of advanced kidney cancer

Triplet therapy slows progression of advanced kidney cancer

Study contributes to better understanding of the changes in kinase activity in renal cell carcinoma

Study contributes to better understanding of the changes in kinase activity in renal cell carcinoma

Study uncovers how common genetic mutations cause renal cancer

Study uncovers how common genetic mutations cause renal cancer

Cytokine-based cancer immunotherapy: current progress and future prospects

Cytokine-based cancer immunotherapy: current progress and future prospects

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Moffitt researchers discover how YAP1 protein contributes to angiogenesis in cancers

Moffitt researchers discover how YAP1 protein contributes to angiogenesis in cancers

Study uncovers novel treatment for chromophobe renal cell carcinoma

Study uncovers novel treatment for chromophobe renal cell carcinoma

Conceptual framework to examine the patterns of copy number alterations in human cancer

Conceptual framework to examine the patterns of copy number alterations in human cancer

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.